Reaction profile

The FDA adverse-event record for infarction

48 FDA reports name infarction, a lower-volume reaction in the CVM extract (VeDDRA 211). Plate stamps and neighbourhood peers follow.

#1757 of 2,481
by report volume (all reactions)
48
reports citing this reaction
77.1%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Infarction has 48 reports now versus 48 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Infarction changes

FDA AER · VeDDRA plate

Code 211 VOL-TRACE

VOL-TRACE · DEATH-HOT · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 48 reports
  • DEATH-HOT 77.1%
  • MID-PACK #1757/2481
  • PHOTO-FINISH Abnormal echocardiogr…
  • SPECIES-DOG Dog · 35
  • DRUG-LEAD Carprofen · 8
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Abnormal echocardiogram (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Infarction

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Abnormal echocardiogr… · near48Application site absc… · near48Brain damage NOS · near48Brain tumour · near48Infarction · this reaction48Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Infarction

Infarction: high death-coded share in the FDA AER plate

Signature read: Infarction's 77.1% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 48 named reports in the openFDA extract. Death-coded share is upper-third: 37 of 48 reports (77.1% of named reports). Nearest volume peer: Abnormal echocardiogram (±0 reports). Lead species Dog (35). Lead co-reported drug Carprofen (8).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 35
Cat 10
Horse 2
Rat 1

Breeds Most Affected

Retriever - Labrador 8
Domestic (unspecified) 3
Domestic Shorthair 3
Dog (unknown) 2
Retriever - Golden 2
Cat (unknown) 2
Quarter Horse 2
Domestic Mediumhair 2
Deutsche Dogge, Great Dane 2
Shepherd Dog - German 1

Associated Drugs

Carprofen 8
Milbemycin Oxime + Spinosad 6
Deracoxib 5
Cefovecin Sodium 3
Oclacitinib Maleate 3
Prednisone 3
Bedinvetmab 3
Enrofloxacin 2
Spinosad 2
Butorphanol Tartrate 2
Maropitant Citrate 2
Metronidazole 2
Ceftiofur Crystalline Free Acid 2
Fluralaner Spot-On Solution 2
Fluralaner Chew Tablets 2
Trilostane 2
Pregabalin 2
Meloxicam 1
Dirlotapide 1
Amoxicillin Clavulanate 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Infarction (#1757 of 2,481 by report volume); death-coded 77.1%. PlainBreed reaction plate · death-coded share stamp 77.1% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →